Log in

Relevant bibliographies by topics / Stomach cancer / Journal articles

To see the other types of publications on this topic, follow the link: Stomach cancer.

Journal articles on the topic 'Stomach cancer'

Author: Grafiati

Published: 4 June 2021

Last updated: 25 July 2025

Create a spot-on reference in APA, MLA, Chicago, Harvard, and other styles

Select a source type:

Consult the top 50 journal articles for your research on the topic 'Stomach cancer.'

Next to every source in the list of references, there is an 'Add to bibliography' button. Press on it, and we will generate automatically the bibliographic reference to the chosen work in the citation style you need: APA, MLA, Harvard, Chicago, Vancouver, etc.

You can also download the full text of the academic publication as pdf and read online its abstract whenever available in the metadata.

Browse journal articles on a wide variety of disciplines and organise your bibliography correctly.

1

Anjani, Mishra Yash Srivastav Nutan Shrivastava Madhaw Kumar. "Characterization of Gastric Cancer (Stomach Cancer) its Situation and Nanotech/Nanoemulsion Treatment: Schematic Overview." International Journal Of Pharmaceutical Sciences 2, no. 12 (2024): 3118–27. https://doi.org/10.5281/zenodo.14555857.

Full text

Abstract:

Your stomach's inner lining is typically where cancer cells start when you have stomach cancer, also known as gastric cancer. As the cancer progresses, it infiltrates your stomach walls more deeply. Early accounts of potential stomach cancer were documented in the Ebers papyrus, which dates back to 1600 BC, and in the Hippocrates reports, which Galen related from Rome in the second century AD. According to legend, Hippocrates was the 18th successor of Aesculapius as Master of the Greek Medical School. He lived in Greece in the fourth century BC, between Kos and Athens. He was the first to use

APA, Harvard, Vancouver, ISO, and other styles

2

Nassir Faisal, Ahmed, Raed Madhi, and Anwar Algaber. "Histological changes and diagnostic value of immunoglobulin G/M to Helicobacter pylori in gastric cancer patients." Bionatura 8, no. 3 (2023): 1–6. http://dx.doi.org/10.21931/rb/2023.08.03.96.

Full text

Abstract:

Stomach cancer is believed to be one of the most common cancers that lead to death. In Iraq, stomach cancer occupies the seventh place of cancer occurrence in both sexes and is counted as one of the ten most common cancers. The current study is designed to explore the link between Helicobacter pylori (H.pylori) infection and the development of incidences of stomach cancer. In addition, related age and gender were also studied. Histological examinations of stomach biopsies were performed in suspected people to evaluate stomach cancer occurrences. Of the 40 patients with stomach cancer, the infe

APA, Harvard, Vancouver, ISO, and other styles

3

Ratner, Yu A. "Stomach cancer." Kazan medical journal 43, no. 6 (2021): 86–87. http://dx.doi.org/10.17816/kazmj83381.

Full text

APA, Harvard, Vancouver, ISO, and other styles

4

Greus, P. Cortina, C. Cortes Vizcaino, J. L. Alfonso Sanchez, D. Carella Piquer, and S. Talamente Serrulla. "Stomach cancer." European Journal of Cancer Prevention 1 (October 1991): 25. http://dx.doi.org/10.1097/00008469-199110001-00042.

Full text

APA, Harvard, Vancouver, ISO, and other styles

5

Packer, P. J., and S. A. Leach. "Stomach cancer." European Journal of Cancer Prevention 1 (October 1991): 26. http://dx.doi.org/10.1097/00008469-199110001-00043.

Full text

APA, Harvard, Vancouver, ISO, and other styles

6

Chan, W. Y. Y., and P. A. Judd. "Stomach cancer." European Journal of Cancer Prevention 1 (October 1991): 26. http://dx.doi.org/10.1097/00008469-199110001-00044.

Full text

APA, Harvard, Vancouver, ISO, and other styles

7

Fontana, V., P. Bruzzi, F. Merlo, et al. "Stomach cancer." European Journal of Cancer Prevention 1 (October 1991): 27. http://dx.doi.org/10.1097/00008469-199110001-00045.

Full text

APA, Harvard, Vancouver, ISO, and other styles

8

Wang, Janet F. "Stomach cancer." Seminars in Oncology Nursing 4, no. 4 (1988): 257–64. http://dx.doi.org/10.1016/0749-2081(88)90077-0.

Full text

APA, Harvard, Vancouver, ISO, and other styles

9

Magnusson, Jonas. "Stomach Cancer." Current Surgery 63, no. 2 (2006): 96–101. http://dx.doi.org/10.1016/j.cursur.2005.10.005.

Full text

APA, Harvard, Vancouver, ISO, and other styles

10

Torpy, Janet M. "Stomach Cancer." JAMA 291, no. 2 (2004): 266. http://dx.doi.org/10.1001/jama.291.2.266.

Full text

APA, Harvard, Vancouver, ISO, and other styles

11

Torpy, Janet M. "Stomach Cancer." JAMA 303, no. 17 (2010): 1771. http://dx.doi.org/10.1001/jama.303.17.1771.

Full text

APA, Harvard, Vancouver, ISO, and other styles

12

Tillyashaykhov, M. N., S. M. Djanklich, S. N. Ibragimov, and O. A. Imamov. "Analysis of cancer incidence structure in the Republic of Uzbekistan." Oncologia i radiologia Kazakhstana 61, no. 3 (2021): 4–8. http://dx.doi.org/10.52532/2663-4864-2021-3-61-4-8.

Full text

Abstract:

Relevance: Globocan reports 19.3 million new cases of malignant neoplasms in 2020 globally. Mammary gland cancer has become the most commonly diagnosed oncological pathology, followed by lung, colon and rectum, prostate, and stomach cancers. In Uzbekistan, malignant neoplasms of the breast, stomach, cervix, lungs, and brain dominate the structure of cancer incidence. The study aimed to analyze the cancer incidence trends and structure in the Republic of Uzbekistan in 2020. Results: In 2020, 21976 new cancer cases were registered in Uzbekistan. The ratio of men and

APA, Harvard, Vancouver, ISO, and other styles

13

TILLYASHAYKHOV, M. N., S. M. Djanklich, S. N. Ibragimov, and O. A. Imamov. "Analysis of cancer incidence structure in the Republic of Uzbekistan." Oncologia i radiologia Kazakhstana 61, no. 3 (2021): 4–8. http://dx.doi.org/10.52532/2521-6414-2021-3-61-4-8.

Full text

Abstract:

Relevance: Globocan reports 19.3 million new cases of malignant neoplasms in 2020 globally. Mammary gland cancer has become the most commonly diagnosed oncological pathology, followed by lung, colon and rectum, prostate, and stomach cancers. In Uzbekistan, malignant neoplasms of the breast, stomach, cervix, lungs, and brain dominate the structure of cancer incidence. The study aimed to analyze the cancer incidence trends and structure in the Republic of Uzbekistan in 2020. Results: In 2020, 21976 new cancer cases were registered in Uzbekistan. The ratio of men and

APA, Harvard, Vancouver, ISO, and other styles

14

Smailova, Dariga S., Serik E. Ibrayev, Satybaldy N. Muzafarov, et al. "Data analysis of a pilot screening program for the early detection of esophageal and gastric cancers: retrospective study." Annals of the Russian academy of medical sciences 74, no. 6 (2020): 405–12. http://dx.doi.org/10.15690/vramn1109.

Full text

Abstract:

BACKGROUND: According to the WHO, in 2018 stomach cancer was the fifth and esophageal cancer seventh most common cancer in the world. In 2011 the National Screening Program for the Early Detection of Breast, Cervical, and Colorectal Cancer was introduced in Kazakhstan. In 2013 a pilot screening program for the early detection of esophageal and stomach cancers was introduced in Kazakhstan in some regions where there is a low detectability. AIM: Determination of the main causes of low detection of esophageal and stomach cancers in the framework of a pilot screening program in Pavlodar regi

APA, Harvard, Vancouver, ISO, and other styles

15

Gurney, Jason, Diana Sarfati, James Stanley, Clarence Kerrison, and Jonathan Koea. "Equity of timely access to liver and stomach cancer surgery for Indigenous patients in New Zealand: a national cohort study." BMJ Open 12, no. 4 (2022): e058749. http://dx.doi.org/10.1136/bmjopen-2021-058749.

Full text

Abstract:

ObjectivesWhen combined, liver and stomach cancers are second only to lung cancer as the most common causes of cancer death for the indigenous Māori population of New Zealand—with Māori also experiencing substantial disparities in the likelihood of survival once diagnosed with these cancers. Since a key driver of this disparity in survival could be access to surgical treatment, we have used national-level data to examine surgical procedures performed on Māori patients with liver and stomach cancers and compared the likelihood and timing of access with the majority European population.Design, p

APA, Harvard, Vancouver, ISO, and other styles

16

Morton, Lindsay M., Sophie D. Fossa, Marilyn Stovall, et al. "Stomach cancer risk following radiotherapy for testicular cancer." Journal of Clinical Oncology 31, no. 15_suppl (2013): 4536. http://dx.doi.org/10.1200/jco.2013.31.15_suppl.4536.

Full text

Abstract:

4536 Background: Testicular cancer (TC) is a highly curable malignancy occurring most commonly among men aged 15-34 years. Survivors are at increased risk for adverse late effects of therapy. Previous studies have reported more than 4-fold risks of stomach cancer after TC, although the potential role of radiotherapy and chemotherapy for TC in these associations is unclear. Methods: We evaluated stomach cancer risk in an international cohort of 23,982 men diagnosed with TC during 1959-1987. Using detailed radiotherapy records, doses to the stomach tumor location were estimated for 92 stomach ca

APA, Harvard, Vancouver, ISO, and other styles

17

Dighikar, Vrushali. "Case report : cancer of stomach." Journal of RURAL NURSING 9, no. 1 (2021): 62–63. http://dx.doi.org/10.54054/jrn.20219115.

Full text

Abstract:

Background: Maximum (about 90% to 95%) gastrointestinal malignancies are adenocarcinomas. Stomach cancer or gastric cancer is almost always an adenocarcinoma. These cancers develop from the cells that form the innermost lining of the stomach (the mucosa). Most people who are diagnosed with stomach cancer are over age 60. Case report: The disease rarely occurs before age 50. In this report, I describe a case of stomach cancer or adenocarcinoma of the stomach. A 60-year-old male name is Gautam Ingle religion is Hindu, lives in the Amravati district and was referred to A.V.B.R. hospital for furth

APA, Harvard, Vancouver, ISO, and other styles

18

Wang, Yuntong, Dong-Woo Choi, Minjin Kim, et al. "Abstract 3622: Racial disparities in second primary cancers in stomach cancer survivors: a comparative study of US and Korea cancer registries." Cancer Research 85, no. 8_Supplement_1 (2025): 3622. https://doi.org/10.1158/1538-7445.am2025-3622.

Full text

Abstract:

Abstract Background: Stomach cancer shows racial disparities in incidence and mortality, influenced by biological, lifestyle, and healthcare factors globally. With improved survival rates, stomach cancer survivors face an elevated risk of second primary cancer (SPC). However, racial differences in SPC risk and post-SPC survival remain unclear. We examined these disparities, leveraging disaggregated racial data from the U.S. and Korea SEER Registries. Methods: Data from 47, 627 U.S. stomach cancer survivors (stage I-III, diagnosed 2000-2021, survival ≥1 year) were analyzed. SPCs were defined as

APA, Harvard, Vancouver, ISO, and other styles

19

Akshayaa, P., B. K. Iyshwarya, and Veerabathiran Ramakrishnan. "Genetic susceptibility to Helicobacter pylori and the progression of gastrointestinal cancer." Research Journal of Biotechnology 19, no. 2 (2023): 95–104. http://dx.doi.org/10.25303/1902rjbt950104.

Full text

Abstract:

The Helicobacter pylori bacteria are spiral-shaped and grow in the stomach's mucus. During its life cycle, H. pylori produces an enzyme called urease that converts urea into ammonia. This enzyme allows the organism to survive a severe, acidic environment by converting urea into ammonia. Molecular genetic studies have identified polymorphisms functional as biomarkers of hereditary predisposition to stomach cancer. Several genes involved in inflammation have been linked to stomach cancer development. Recently, these genes' potential pathogenic and carcinogenic effects have been investigated (APC

APA, Harvard, Vancouver, ISO, and other styles

20

Liu, Yu, Yan Zhao, Chongxu Han, and Chuanli Ren. "Expression of CDK6 in Stomach Cancer and the Effect of CDK4/6 Inhibitor PD-0332991 on the Function of Stomach Cancer Cells." Computational and Mathematical Methods in Medicine 2022 (April 30, 2022): 1–8. http://dx.doi.org/10.1155/2022/2402567.

Full text

Abstract:

Objective. To study the expression and prognostic value of CDK6 in stomach cancer and the function of CDK4/6 inhibitor PD-0332991 on the proliferation of stomach cancer cells. Methods. Immunohistochemistry was used to detect the expression of CDK6 in stomach cancer tissues and adjacent normal tissues and to analyze the effect of CDK6 on clinicopathological parameters of stomach cancer patients. Kaplan-Meier plotter was employed to study the relationship between CDK6 and overall survival in stomach cancer. Western blot and RT-PCR were used to detect protein and gene expression of CDK6 in differ

APA, Harvard, Vancouver, ISO, and other styles

21

Kawakatsu, Yukino, Yuriko N. Koyanagi, Isao Oze, et al. "Association between Socioeconomic Status and Digestive Tract Cancers: A Case-Control Study." Cancers 12, no. 11 (2020): 3258. http://dx.doi.org/10.3390/cancers12113258.

Full text

Abstract:

Although socioeconomic status (SES) has been associated with cancer risk, little research on this association has been done in Japan. To evaluate the association between SES and digestive tract cancer risk, we conducted a case-control study for head and neck, esophageal, stomach, and colorectal cancers in 3188 cases and the same number of age- and sex-matched controls within the framework of the Hospital-based Epidemiological Research Program at Aichi Cancer Center III (HERPACC III). We employed the education level and areal deprivation index (ADI) as SES indicators. The association was evalua

APA, Harvard, Vancouver, ISO, and other styles

22

Kerr, William C., and Yu Ye. "US Time Series Evidence regarding Alcohol-Related Risk of Oral Cancers and Protection against Stomach Cancers: Are Higher Concentration Beverages Different?" Contemporary Drug Problems 34, no. 3 (2007): 495–511. http://dx.doi.org/10.1177/009145090703400308.

Full text

Abstract:

Autoregressive integrated moving average modeling procedures are utilized on population-level mortality rates for oral and stomach cancers in relation to per capita consumption of total alcohol, beer, wine, spirits and cigarettes to estimate long-term population-level relationships between alcohol consumption series and oral and stomach cancer mortality rates, and to determine whether higher-concentration alcoholic beverages, as represented by spirits, are more strongly related to these cancers than beer or wine. Total alcohol consumption is found to increase oral cancer rates by 3.5% per litr

APA, Harvard, Vancouver, ISO, and other styles

23

Qazi, Tanzeela Bashir. "Delay in Diagnosis of Stomach Cancer patients attending a Tertiary Care Hospital in Kashmir: a Hospital Based Cross Sectional Study." Healthline 13, no. 4 (2022): 295–300. http://dx.doi.org/10.51957//healthline_414_2022.

Full text

Abstract:

Introduction: The incidence of cancer is increasing throughout the world. However, early detection of cancers is associated with a favourable outcome. Stomach cancer is one of the most common cancers of gastrointestinal tract. Majority patients visit physicians in developed stages. Objective: To evaluate the reporting pattern of stomach cancer patients living in Kashmir valley in order to determine the median time of delay from the beginning of symptoms to diagnosis. Method: Total 116 proven stomach cancer patients were evaluated for the pattern of presentation at endoscopy laboratory of Super

APA, Harvard, Vancouver, ISO, and other styles

24

Roychowdhury, Anasuya, Aditi Nayak, Sugandh Kumar, Anshuman Dixit та Asima Bhattacharyya. "Abstract 5680: Hypoxia-responsive and HIF1α-regulated AAA+ ATPase ATAD2 shows high oncogenic potential in stomach cancer". Cancer Research 82, № 12_Supplement (2022): 5680. http://dx.doi.org/10.1158/1538-7445.am2022-5680.

Full text

Abstract:

Abstract The burden of stomach cancer incidence and death is a global challenge. Treating stomach cancer remains immensely difficult due to the lack of available markers to detect the disease at the early stages. Therefore, there is an immense demand for finding out an early detection biomarker for stomach cancer. Recently, ATAD2 is found to be overexpressed in stomach cancer with high prognostic significance and recognised as a promising biomarker for stomach cancer. ATAD2 is a unique cancer/testis antigen (CTA) that belongs to both AAA+ ATPase and bromodomain family proteins. However, nothin

APA, Harvard, Vancouver, ISO, and other styles

25

Boyarskikh, Ulyana, Andrey Kechin, Evgeniy Khrapov, et al. "Detecting Microsatellite Instability in Endometrial, Colon, and Stomach Cancers Using Targeted NGS." Cancers 15, no. 20 (2023): 5065. http://dx.doi.org/10.3390/cancers15205065.

Full text

Abstract:

Purpose: To develop a method for testing the MSI based on targeted NGS. Methods: Based on the results of previous studies, 81 microsatellite loci with high variability in MSI-H tumors were selected, and a method for calculating the MSI score was developed. Using the MSI score, we defined the MSI status in endometral (162), colon (153), and stomach (190) cancers. Accuracy of the MSI scores was evaluated by comparison with MMR immunohistochemistry for 137 endometrium (63 dMMR and 74 pMMR), 76 colon (29 dMMR and 47 pMMR), and 81 stomach (8 dMMR and 73 pMMR) cancers. Results: Classification of MSS

APA, Harvard, Vancouver, ISO, and other styles

26

Vishi, Imri, Agron Dogjani, Arben Gjata, Kastriot Haxhirexha, and Hysni Bendo. "Some epidemiological data about Stomach Cancer in Kosovo." Albanian Journal of Trauma and Emergency Surgery 5, no. 2 (2021): 864–68. http://dx.doi.org/10.32391/ajtes.v5i2.232.

Full text

Abstract:

Despite the continuing decline in incidence, stomach cancer remains one of the most common and deadly neoplasms in the world [1]. According to the literature, stomach cancer is the third leading cause of cancer deaths worldwide, ranking third after lung cancer and colorectal in global cancer mortality. About 1 in 12 neoplasm deaths can be attributed to stomach cancer, which has 5 times the highest incidence among all cancers, and over one million new cases of stomach cancer are diagnosed each year worldwide.[2] Our objectives were: Evidence and detailed statistical description of demogra

APA, Harvard, Vancouver, ISO, and other styles

27

Zhuravleva, N. V., A. V. Samoilova, I. Yu Dolgov, et al. "Stomach cancer and pregnancy." Problemy reproduktsii 27, no. 5 (2021): 130. http://dx.doi.org/10.17116/repro202127051130.

Full text

APA, Harvard, Vancouver, ISO, and other styles

28

Chang, Jae Chan. "Perspectives on stomach cancer." Journal of Korean Medical Science 9, no. 4 (1994): 277. http://dx.doi.org/10.3346/jkms.1994.9.4.277.

Full text

APA, Harvard, Vancouver, ISO, and other styles

29

Elder, J. B. "Cancer of the stomach." Current Opinion in Gastroenterology 2, no. 6 (1986): 889–95. http://dx.doi.org/10.1097/00001574-198611000-00015.

Full text

APA, Harvard, Vancouver, ISO, and other styles

30

Wanebo, Harold J., B. J. Kennedy, Joan Chmiel, Glenn Steele, David Winchester, and Robert Osteen. "Cancer of the Stomach." Annals of Surgery 218, no. 5 (1993): 583–92. http://dx.doi.org/10.1097/00000658-199321850-00002.

Full text

APA, Harvard, Vancouver, ISO, and other styles

31

Elder, J. B. "Cancer of the stomach." Current Opinion in Gastroenterology 1, no. 6 (1985): 874–80. http://dx.doi.org/10.1097/00001574-198511000-00012.

Full text

APA, Harvard, Vancouver, ISO, and other styles

32

Clark, P. I., and M. L. Slevin. "Chemotherapy for stomach cancer." BMJ 295, no. 6603 (1987): 870–71. http://dx.doi.org/10.1136/bmj.295.6603.870-a.

Full text

APA, Harvard, Vancouver, ISO, and other styles

33

Barbosa-Lorenzo, Raquel, Juan M. Barros-Dios, and Alberto Ruano-Ravina. "Radon and stomach cancer." International Journal of Epidemiology 46, no. 2 (2017): 767–68. http://dx.doi.org/10.1093/ije/dyx011.

Full text

APA, Harvard, Vancouver, ISO, and other styles

34

Mathew, A., P. Gangadharan, C. Varghese, and M. K. Nair. "Diet and stomach cancer." European Journal of Cancer Prevention 9, no. 2 (2000): 89–98. http://dx.doi.org/10.1097/00008469-200004000-00004.

Full text

APA, Harvard, Vancouver, ISO, and other styles

35

Sun, J., J. Misumi, A. Shimaoka, K. Aoki, and F. Esaki. "Stomach cancer-related mortality." European Journal of Cancer Prevention 10, no. 1 (2001): 61–67. http://dx.doi.org/10.1097/00008469-200102000-00007.

Full text

APA, Harvard, Vancouver, ISO, and other styles

36

Chan, WH, and WK Wong. "Stomach Cancer: An Overview." Cancer Reviews: Asia-Pacific 02, no. 01 (2004): 81–91. http://dx.doi.org/10.1142/s021983630400041x.

Full text

APA, Harvard, Vancouver, ISO, and other styles

37

Pezet, Denis, Pierre Michel, Christine Rebischung, and Marc Ychou. "Cancer of the stomach." Gastroentérologie Clinique et Biologique 30 (September 2006): 16–23. http://dx.doi.org/10.1016/s0399-8320(06)73585-0.

Full text

APA, Harvard, Vancouver, ISO, and other styles

38

Purtilo, DavidT, and Fernando Merino. "IMMUNODEFICIENCY AND STOMACH CANCER." Lancet 325, no. 8431 (1985): 751. http://dx.doi.org/10.1016/s0140-6736(85)91284-x.

Full text

APA, Harvard, Vancouver, ISO, and other styles

39

O'Neill, Paul. "Stomach bug causes cancer." Trends in Molecular Medicine 7, no. 11 (2001): 491. http://dx.doi.org/10.1016/s1471-4914(01)02210-9.

Full text

APA, Harvard, Vancouver, ISO, and other styles

40

Goldner, Fred. "Cancer of the stomach." Gastroenterology 92, no. 6 (1987): 2045. http://dx.doi.org/10.1016/0016-5085(87)90653-6.

Full text

APA, Harvard, Vancouver, ISO, and other styles

41

Miller, Andrew. "Diet and stomach cancer." Food and Chemical Toxicology 24, no. 5 (1986): 437–38. http://dx.doi.org/10.1016/0278-6915(86)90218-8.

Full text

APA, Harvard, Vancouver, ISO, and other styles

42

Burr, M. L., and Ruth M. Holliday. "Fruit and stomach cancer." Journal of Human Nutrition and Dietetics 2, no. 4 (1989): 273–77. http://dx.doi.org/10.1111/j.1365-277x.1989.tb00029.x.

Full text

APA, Harvard, Vancouver, ISO, and other styles

43

Toffoli, Giuseppe, and Erika Cecchin. "Pharmacogenomics and stomach cancer." Pharmacogenomics 5, no. 6 (2004): 627–41. http://dx.doi.org/10.1517/14622416.5.6.627.

Full text

APA, Harvard, Vancouver, ISO, and other styles

44

Kono, Suminori, and Tomio Hirohata. "Nutrition and stomach cancer." Cancer Causes and Control 7, no. 1 (1996): 41–55. http://dx.doi.org/10.1007/bf00115637.

Full text

APA, Harvard, Vancouver, ISO, and other styles

45

Inoue, Haruhiro. "Endoscopic Mucosal Resection for Esophageal and Gastric Mucosal Cancers." Canadian Journal of Gastroenterology 12, no. 5 (1998): 355–59. http://dx.doi.org/10.1155/1998/535978.

Full text

Abstract:

Accumulated data from surgically resected specimens reveal that mucosal cancers of the esophagus and stomach pose low risk of lymph node metastasis. The author used endoscopic mucosal resection (EMR) as curative treatment in 142 cases of esophageal cancer and 102 cases of stomach cancer. In absolutely indicated cases there has been no local or distant metastasis during the longest period of follow-up (nine years). One perforation and one post-treatment severe stenosis, which was resistant to dilation therapy in the esophagus, were encountered. Deeper layer resection (including partial proper m

APA, Harvard, Vancouver, ISO, and other styles

46

Kogoniya, L. M., L. E. Gurevich, V. S. Mazurin, and E. V. Markarova. "Experience of long-term clinical observation of a patient with a rare type of stomach cancer – lymphoepithelioma-like carcinoma." Meditsinskiy sovet = Medical Council, no. 9 (July 30, 2020): 277–82. http://dx.doi.org/10.21518/2079-701x-2020-9-277-282.

Full text

Abstract:

Stomach cancer is one of the most frequently diagnosed cancers. The success of special methods of treatment are still disappointing in this disease, and stomach cancer has historically been considered a tumor refractory to treatment. Therefore, this category of patients, especially in the stage of dissemination, in most cases, palliative therapy is recommended. In recent years, the use of systemic chemotherapy and targeted therapy has led to a significant improvement in the quality of life and survival rates for stomach cancer compared to palliative therapy. However, significant progress in di

APA, Harvard, Vancouver, ISO, and other styles

47

Tsukanov, V. V., A. V. Vasyutin, and Yu L. Tonkikh. "Modern Aspects of Stomach Cancer Prevention." Doctor.Ru 19, no. 7 (2020): 37–40. http://dx.doi.org/10.31550/1727-2378-2020-19-7-37-40.

Full text

Abstract:

Objective of the Review: to analyse available data on stomach cancer prevention. Key Points. Key risk factors for stomach cancer are male gender, age of >50 years old, Helicobacter pylori and smoking. A number of international consensus opinions regulate screening, diagnostics and treatment of precancer changes in stomach; it is assumed to reduce the incidence of this disease. H. pylori eradication is the key method of primary stomach cancer prevention. Modern studies demonstrate that the optimal method of H. pylori eradication is the therapy with bismuth medication, proton pump inhibitor,

APA, Harvard, Vancouver, ISO, and other styles

48

Oncina-Cánovas, Alejandro, Laura Torres-Collado, Manuela García-de-la-Hera, et al. "Association Between Dairy Products Consumption and Esophageal, Stomach, and Pancreatic Cancers in the PANESOES Multi Case–Control Study." Cancers 16, no. 24 (2024): 4151. https://doi.org/10.3390/cancers16244151.

Full text

Abstract:

Background/Objectives: This study explored the association between dairy products consumption (total and subgroups) and cancer of the esophagus, stomach, and pancreas within the PANESOES case–control study. Methods: Data from 1229 participants, including 774 incident cases of cancer and 455 controls matched by age, sex, and region, were analyzed. Dietary intake was assessed using a validated Food Frequency Questionnaire, categorizing dairy intake by total and subgroups (fermented dairy, sugary dairy desserts, and milk). Multinomial logistic regression was used to estimate relative risk ratios

APA, Harvard, Vancouver, ISO, and other styles

49

Toyoda, Yasuhiro, Takahiro Tabuchi, Hitomi Hama, Toshitaka Morishima, and Isao Miyashiro. "Trends in clinical stage distribution and screening detection of cancer in Osaka, Japan: Stomach, colorectum, lung, breast and cervix." PLOS ONE 15, no. 12 (2020): e0244644. http://dx.doi.org/10.1371/journal.pone.0244644.

Full text

Abstract:

We examined clinical stage distribution and proportion of screen-detected cases of stomach, colorectal, lung, female breast and cervical cancer by sex and age group using Osaka Cancer Registry data from 2000–2014. The proportion of local or in situ stage cancer had increased for all age groups in all sites, except stomach cancer in the 0–49 years group and female breast cancer in the 80 years and older group. The proportion of screen-detected cases had increased during the study period for all age groups in all cancer sites. While the proportion increased noticeably in the younger groups, ther

APA, Harvard, Vancouver, ISO, and other styles

50

Kobia, Francis, Jesse Gitaka, Francis Makokha, et al. "The state of cancer in Meru, Kenya: a retrospective study." AAS Open Research 2 (December 3, 2019): 167. http://dx.doi.org/10.12688/aasopenres.13027.1.

Full text

Abstract:

Background: It is projected that by 2030, 70% of all cancer related deaths will occur in low-middle income countries. However, data on the state of cancer in most African countries is scanty. Cancer estimates for Kenya are based on the Nairobi and Eldoret cancer registries, leaving most parts of the country unrepresented. Lacking national coverage, these data do not accurately reflect Kenya’s cancer burden. The paucity of reliable data impedes formulation of effective cancer control strategies and cancer research prioritization. Here, we report the findings of a retrospective study of the canc

APA, Harvard, Vancouver, ISO, and other styles

We offer discounts on all premium plans for authors whose works are included in thematic literature selections. Contact us to get a unique promo code!